Kyle Piskel - Net Worth and Insider Trading

Kyle Piskel Net Worth

The estimated net worth of Kyle Piskel is at least $884,311 dollars as of 2024-11-29. Kyle Piskel is the CFO of Adaptive Biotechnologies Corp and owns about 154,330 shares of Adaptive Biotechnologies Corp (ADPT) stock worth over $884,311. Details can be seen in Kyle Piskel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kyle Piskel has not made any transactions after 2024-11-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kyle Piskel

To

Kyle Piskel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kyle Piskel owns 1 companies in total, including Adaptive Biotechnologies Corp (ADPT) .

Click here to see the complete history of Kyle Piskel’s form 4 insider trades.

Insider Ownership Summary of Kyle Piskel

Ticker Comapny Transaction Date Type of Owner
ADPT Adaptive Biotechnologies Corp 2024-11-18 Principal Accounting Officer

Kyle Piskel Latest Holdings Summary

Kyle Piskel currently owns a total of 1 stock. Kyle Piskel owns 154,330 shares of Adaptive Biotechnologies Corp (ADPT) as of November 18, 2024, with a value of $884,311.

Latest Holdings of Kyle Piskel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ADPT Adaptive Biotechnologies Corp 2024-11-18 154,330 5.73 884,311

Holding Weightings of Kyle Piskel


Kyle Piskel Form 4 Trading Tracker

According to the SEC Form 4 filings, Kyle Piskel has made a total of 7 transactions in Adaptive Biotechnologies Corp (ADPT) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Adaptive Biotechnologies Corp is the sale of 248 shares on November 18, 2024, which brought Kyle Piskel around $1,235.

Insider Trading History of Kyle Piskel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kyle Piskel Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kyle Piskel Ownership Network

Ownership Network List of Kyle Piskel

No Data

Ownership Network Relation of Kyle Piskel

Insider Network Chart

Kyle Piskel Owned Company Details

What does Adaptive Biotechnologies Corp do?

Who are the key executives at Adaptive Biotechnologies Corp?

Kyle Piskel is the Principal Accounting Officer of Adaptive Biotechnologies Corp. Other key executives at Adaptive Biotechnologies Corp include SVP and General Counsel Stacy L Taylor , Chief Commercial Ofc Imm Med Sharon Benzeno , and Chief Financial Officer Tycho Peterson .

Adaptive Biotechnologies Corp (ADPT) Insider Trades Summary

Over the past 18 months, Kyle Piskel made 3 insider transaction in Adaptive Biotechnologies Corp (ADPT) with a net sale of 8,234. Other recent insider transactions involving Adaptive Biotechnologies Corp (ADPT) include a net sale of 258,417 shares made by Tycho Peterson , a net sale of 40,303 shares made by Stacy L Taylor , and a net sale of 48,673 shares made by Chad M Robins .

In summary, during the past 3 months, insiders sold 248 shares of Adaptive Biotechnologies Corp (ADPT) in total and bought 0 shares, with a net sale of 248 shares. During the past 18 months, 467,980 shares of Adaptive Biotechnologies Corp (ADPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 467,980 shares.

Adaptive Biotechnologies Corp (ADPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adaptive Biotechnologies Corp Insider Transactions

No Available Data

Kyle Piskel Mailing Address

Above is the net worth, insider trading, and ownership report for Kyle Piskel. You might contact Kyle Piskel via mailing address: C/o Adaptive Biotechnologies Corporation, 1551 Eastlake Ave E Ste 200, Seattle Wa 98102.

Discussions on Kyle Piskel

No discussions yet.